Chitosan-carboxymethylcellulose interpolymer complexes for gastric-specific delivery of clarithromycin

International Journal of Pharmaceutics

Volumn 359, Issue 1-2, 2008, Pages 135-143

  Gomez Burgaz M ^a   Garcia Ochoa B ^a   Torrado Santiago, S ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Carboxymethylcellulose sodium; Chitosan; Clarithromycin; Gastroretentive systems; Interpolymer complexes

Indexed keywords

CARBOXYMETHYLCELLULOSE; CHITOSAN; CLARITHROMYCIN; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG SOLUBILITY; DRUG UPTAKE; ELECTRICITY; HYDROGEL; IONIZATION; MOLECULAR INTERACTION; MOLECULAR WEIGHT; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TABLET FORMULATION;

ANTI-BACTERIAL AGENTS; CAPSULES; CARBOXYMETHYLCELLULOSE; CHITOSAN; CLARITHROMYCIN; DIFFUSION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; KINETICS; MOLECULAR WEIGHT; POLYMERS; SOLUBILITY; STOMACH; TABLETS;

EID: 44749094010     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.03.042     Document Type: Article

References (31)

1. Bardonnet P.L., Faivre V., Pugh W.J., and Piffaretti J.C. Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J. Control. Release 111 (2006) 1-18 (Review)
2. Chellat F., Tabrizian M., Dimitriu S., Chornet E., Rivard C.H., and Yahia L. Study of biodegradation behaviour of chitosan-xanthan microspheres in simulated physiological media. J. Biomed. Mater. Res. 53 (2000) 592-599
3. Chun M.-K., Sah H., and Choi H.-K. Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori. Int. J. Pharm. 297 (2005) 172-179
4. Conti S., Maggi L., Segale L., Ochoa Machiste E., Conte U., Grenier P., and Vergnault G. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int. J. Pharm. 333 (2007) 136-142
5. Conti S., Maggi L., Segale L., Ochoa Machiste E., Conte U., Grenier P., and Vergnault G. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism studies. Int. J. Pharm. 333 (2007) 143-151
6. Conway B.R. Drug delivery strategies for the treatment of Helicobacter pylori infections. Curr. Pharm. Des. 11 (2005) 775-790 (Review)
7. De la Torre P.M., Enobakhare Y., Torrado G., and Torrado S. Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid). Study of polymer/polymer and polymer/drug interactions within the network structure. Biomaterials 24 (2003) 1499-1506
8. De la Torre P.M., Torrado G., and Torrado S. Poly(acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. Biomed. Mater. Res. Part B: Appl. Biomater. 72 (2005) 191-197
9. Di Mario F., Cavallaro L.G., and Scarpignato C. 'Rescue' therapies for the management of Helicobacter pylori infection. World J. Gastroenterol. 12 (2006) 2313-2319
10. Erah P.O., Goddard A.F., Barrett D.A., Shaw P.N., and Spiller R.C. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J. Antimicrob. Chemother. 39 (1997) 5-12
11. Foda N.H., El-laithy H.M., and Tadros M.I. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties. Drug Dev. Ind. Pharm. 30 (2004) 369-379
12. Kavanagh N., and Corrigan O.I. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices-influence of agitation rate and dissolution medium composition. Int. J. Pharm. 279 (2004) 141-152
13. Lee K.Y., Park W.H., and Ha W.S. Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives for microcapsules. J. Appl. Polym. Sci. 63 (1997) 425-432
14. Li Y.H., and Zhu J.B. Modulation of combined-release behaviors from a novel "tablets-in-capsule system". J. Control. Release 95 (2004) 381-389
15. Lim Soo P., Cho J., Grant J., Ho E., Piquette-Miller M., and Allen C. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology. Eur. J. Pharm. Biopharm. 69 (2008) 149-157
16. Lin W.-C., Yu D.-G., and Yang M.-C. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties. Colloids Surf. B: Biointerfaces 44 (2005) 143-151
17. Loke W.K., Lau S.K., Lim-Lee-Yong, Khor E., and Chow-Kok-Sum. Wound dressing with sustained anti-microbial capability. J. Biomed. Mater. Res. 53 (2000) 8-17
18. Majithiya R.J., and Murthy R.S. Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach. Curr. Drug Deliv. 2 (2005) 235-242
19. Mladenovska K., Raicki R.S., Janevik E.I., Ristoski T., Pavlova M.J., Kavrakovski Z., Dodov M.G., and Goracinova K. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int. J. Pharm. 342 (2007) 124-136
20. Nakagawa Y., Itai S., Yoshida T., and Nagai T. Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chem. Pharm. Bull. 40 (1992) 725-728
21. Nerurkar J., Jun H.W., Price J.C., and Park M.O. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factor on dissolution rates. Eur. J. Pharm. Biopharm. 61 (2005) 56-68
22. Park H., Park K., and Kim D. Preparation and swelling behaviour of chitosan-based superporous hydrogels for gastric retention application. J. Biomed. Mater. Res. A 76 (2006) 144-150
23. Patel J.K., and Patel M.M. Stomach specific anti-Helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres. Curr. Drug Deliv. 4 (2007) 41-50
24. Puttipipatkhachorn S., Nunthanid J., Yamamoto K., and Peck G.E. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. J. Control. Release 75 (2001) 143-153
25. Ritger P.L., and Peppas N.A. A simple equation for the description of solute release I. Fickian and non-Fickian release from non-swellable devices in form of slabs, sphere, cylinders or discs. J. Control. Release 5 (1987) 23-36
26. Sakiyama T., Takata H., Kikuchi M., and Nakanishi K. Polyelectrolyte complex gel with high pH-sensitivity prepared from dextran sulfate and chitosan. J. Appl. Polym. Sci. 73 (1999) 2227-2233
27. Shah A.C. Design of oral sustained release drug delivery systems: in-vitro/in-vivo considerations. In: Yacobi A., and Haperin-Walega E. (Eds). Oral Sustained Release Formulations Design and Evaluation (1988), Pergamon Press, New York 35-56
28. Stedman C.A.M., and Barclay M.L. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment. Pharmacol. Ther. 14 (2000) 963-978
29. Suzuki H., Marshall B.J., and Hibi T. Overview: Helicobacter pylori and extragastric disease. Int. J. Hematol. 84 (2006) 291-300 (Review)
30. Van Tomme S.R., van Nostrum C.F., de Smedt S.C., and Hennik W.E. Degradation behaviour of dextran hydrogels composed of positively and negatively charged microspheres. Biomaterials 27 (2006) 4141-4148
31. Verhoeven E., Vervaet C., and Remon J.P. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 63 (2006) 320-330